BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• BioForest

  BioLife Solutions, Inc. To Present At Upcoming Investor Conferences

  September 28, 2015

   · 

  1 min read
• Drug Development

  Synthetic Biologics, Inc. Initiates SYN-004 Phase 2b Proof-of-Concept Clinical Trial

  September 28, 2015

   · 

  7 min read
• Drug Development

  Patients With Aggressive Form Of Melanoma Lived For More Than Two Years On Average When Taking Novartis Pharmaceutical Corporation Therapies Tafinlar + Mekinist

  September 28, 2015

   · 

  16 min read
• Drug Development

  Eli Lilly’s CYRAMZA (ramucirumab) Significantly Improves Progression-Free Survival In Phase II Bladder Cancer Trial

  September 28, 2015

   · 

  23 min read
• BioMidwest

  Akorn, Inc. Launches Myorisan(TM) 30 mg Capsules

  September 28, 2015

   · 

  4 min read
• Drug Development

  Genentech’s New Drug Shows Benefits in Phase II Lung, Bladder Cancer Tests

  September 28, 2015

   · 

  7 min read
• Policy

  Sanofi, Eli Lilly Reach Patent Deal on Lantus SoloSTAR

  September 28, 2015

   · 

  2 min read
• Oncolytics Biotech Inc. Collaborators Present Data From Clinical Study In Multiple Myeloma

  September 28, 2015

   · 

  6 min read
• BioMidwest

  KMR Group Release: Site Metrix Illuminates Trial Planning Opportunities

  September 28, 2015

   · 

  2 min read
• Business

  Teijin Pharma To Collaborate With Peptidream In Peptide Discovery

  September 28, 2015

   · 

  1 min read